SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Supriya Lifescience informs about newspaper advertisement

01 Jul 2023 Evaluate

In terms of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Supriya Lifescience has informed that it enclosed copies of the newspaper advertisement extract for Postal Ballot Notice published in the newspapers, Financial Express (English Language) and Loksatta (Marathi Language) on July 1, 2023.

The above information is a part of company’s filings submitted to BSE.

Supriya Lifescience Share Price

641.05 4.15 (0.65%)
15-Apr-2026 11:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1676.80
Dr. Reddys Lab 1218.50
Cipla 1223.95
Zydus Lifesciences 935.00
Lupin 2352.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×